₹4.22
−3.87%BSE close, 16 Nov 2026
−80.68%
DIPNA PHARMACHEM is a small cap company in the Healthcare sector, listed on BSE SME under the symbol DPL (BSE code 543594). At ₹4.22 a share, the market values the whole company at ₹11 crore. BSE SME is the exchange's platform for small and medium companies, which report their results every half year.
Over the past year the share price has fallen 78.0%, and it is 78.8% below its 52-week high.
Companies of a similar size in the same sector include STARSOURCE MULTITRADE, DESH RAKSHAK AUSHDHALAYA, Vanta Bioscience and UNJHA FORMULATIONS.
Listed on BSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
This company is listed only on BSE, so its page shows price figures only: results and shareholding on RupeeVerse come from companies’ NSE filings.
The same sector (Healthcare), nearest in size.
| Company | Price | Market cap | P/E | ROE | Sales growth | 1Y |
|---|---|---|---|---|---|---|
| DIPNA PHARMACHEM | ₹4.22 | ₹11 cr | n/a | n/a | n/a | −77.97% |
| STARSOURCE MULTITRADE | ₹91.75 | ₹14 cr | n/a | n/a | n/a | −22.28% |
| DESH RAKSHAK AUSHDHALAYA | ₹23.50 | ₹13 cr | n/a | n/a | n/a | −34.17% |
| Vanta Bioscience | ₹18.50 | ₹13 cr | n/a | n/a | n/a | −33.19% |
| UNJHA FORMULATIONS | ₹27.87 | ₹12 cr | n/a | n/a |
| n/a |
| +21.23% |
| BERYL DRUGS | ₹24.59 | ₹12 cr | n/a | n/a | n/a | +6.45% |
|---|
| DOLPHIN MEDICAL SERVICES | ₹7.83 | ₹12 cr | n/a | n/a | n/a | +274.64% |
|---|
| FAMILY CARE HOSPITALS | ₹1.91 | ₹10 cr | n/a | n/a | n/a | −52.72% |
|---|
| DHANVANTRI JEEVAN REKHA | ₹23.00 | ₹9 cr | n/a | n/a | n/a | −14.34% |
|---|